| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |